GCS Ramsay Santé pour l'Enseignement et la Recherche

ramsaygds.fr

Total trials

139

Active

74

Phase 3

2

Total enrollment

82,073

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 9 of 9 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Morphine2
Lidocaine IV1
Botulinum toxin1
Sodium Chloride2
Neuroleptanalgesia1
24 hours antibiotics1
48 hours antibiotics1
Intravenous lidocaine administration1
Neuroleptanalgesic treatment1

Next readouts

  • 2025-09
  • 2025-11-30
  • 2026-01-18
  • 2026-05-31
  • 2026-11
  • 2027-07-30
  • 2027-08-31

Top conditions

  • Prostate Cancer5
  • ACL - Anterior Cruciate Ligament Rupture4
  • Analgesia3
  • Gonarthrosis3
  • Chronic Ankle Instability2
  • ACL - Anterior Cruciate Ligament Deficiency2
  • Orthopedic Disorder2
  • Shoulder Pain2

Frequently asked questions about GCS Ramsay Santé pour l'Enseignement et la Recherche

How many clinical trials does GCS Ramsay Santé pour l'Enseignement et la Recherche have on ClinicalTrials.gov?
GCS Ramsay Santé pour l'Enseignement et la Recherche is listed as the lead sponsor on 139 clinical trials in ClinicalTrials.gov, 74 of which are currently active (recruiting, enrolling, or ongoing).
How many of GCS Ramsay Santé pour l'Enseignement et la Recherche's trials are in Phase 3?
2 of GCS Ramsay Santé pour l'Enseignement et la Recherche's trials are in Phase 3, spread across 9 active drug programs.
What therapeutic areas does GCS Ramsay Santé pour l'Enseignement et la Recherche focus on?
GCS Ramsay Santé pour l'Enseignement et la Recherche's most-studied conditions on ClinicalTrials.gov are Prostate Cancer, ACL - Anterior Cruciate Ligament Rupture, Analgesia, Gonarthrosis, Chronic Ankle Instability.
When are GCS Ramsay Santé pour l'Enseignement et la Recherche's next clinical trial readouts?
GCS Ramsay Santé pour l'Enseignement et la Recherche has 7 upcoming primary-completion readouts tracked here; the soonest is “Evaluation of the Benefit and Safety of Localized Tissue Hydration in the Management of Chronic Low Back Pain”, expected around 2025-09.